
Insider and congress filings
Tenet Healthcare Corporation (THC)
NYSE · Healthcare · 323 insider filings · 9 congress trades · last filed 8 days ago
About Tenet Healthcare Corporation
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Saumya Sutaria
- Employees
- 88,500
- Listed since
- -
- Market value
- $21.7B
- Price to earnings
- 10.3
- Earnings per share
- $26.83
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 27, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 23, 2026 | $6.12 | $4.26 | $5.6B | $5.4B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $4.82 | $4.17 | $5.4B | $5.4B | EPS beatRevenue in line |
| Q4 FY2025reported Feb 11, 2026 | $4.70 | $4.07 | $5.5B | $5.5B | EPS beatRevenue in line |
| Q3 FY2025reported Oct 28, 2025 | $3.70 | $3.34 | $5.3B | $5.3B | EPS beatRevenue in line |
| Q2 FY2025reported Jul 22, 2025 | $4.02 | $2.87 | $5.3B | $5.2B | EPS beatRevenue beat |
| Q1 FY2025reported Apr 29, 2025 | $4.36 | $3.12 | $5.2B | $5.1B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 16, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Saum SutariaChairman and Chief Executive Officer | $1.5M | $31.7M | $9.9M | $43.1M |
| Tom ArnstEVP, Chief Administrative Officer, General Counsel and | $650K | $3.7M | $5.7M | $10.0M |
| Lisa FooEVP and Chief Operating Officer | $650K | $3.4M | $5.5M | $9.5M |
| Sun ParkEVP and Chief Financial Officer | $700K | $2.7M | $4.0M | $7.4M |
| Paola ArbourEVP and Chief Information Officer | $550K | $1.4M | $2.2M | $4.1M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $1.6B | 8,743,005 | +0.4% | 10.47% |
| Price T Rowe Associates Inc | $1.5B | 7,957,449 | +5.8% | 9.53% |
| Boston Partners | $829.1M | 4,433,360 | +15.6% | 5.31% |
| Vanguard Portfolio Management LLC | $792.9M | 4,238,108 | -1.8% | 5.07% |
| FMR LLC | $747.3M | 3,994,545 | -48.6% | 4.78% |
| Vanguard Capital Management LLC | $728.5M | 3,894,189 | -0.4% | 4.66% |
| State Street Corp | $514.7M | 2,751,290 | +1.3% | 3.29% |
| Glenview Capital Management, LLC | $418.2M | 2,235,666 | +46.6% | 2.68% |
| Geode Capital Management, LLC | $352.7M | 1,884,982 | -2.4% | 2.26% |
| Citadel Advisors LLC | $330.3M | 1,765,596 | +321.6% | 2.11% |
| Arrowstreet Capital, Limited Partnership | $319.6M | 1,708,453 | +154.3% | 2.05% |
| Ameriprise Financial Inc | $311.5M | 1,664,068 | +11.5% | 1.99% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Open-market insider trades
18 filings of 323 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Nadja WestDirector | Sold | 1,152 | $258.80 | $298K | Sep 2, 2026 | 1d |
| Lisa Y. FooEVP, Chief Operating Officer | Sold | 24,000 | $266.32 | $6.4M | Aug 31, 2026 | 1d |
| Cecil D. HaneyDirector | Sold | 1,300 | $278.03 | $361K | Aug 24, 2026 | 2d |
| Saumya SutariaCEO | Sold · 2 lines | 50,000 | $278.71 | $13.9M | Aug 24, 2026 | 2d |
| Saumya SutariaCEO | Sold · 3 lines | 50,000 | $274.02 | $13.7M | Aug 25, 2026 | 1d |
| Tammy RomoDirector | Sold | 2,500 | $260.83 | $652K | Aug 7, 2026 | 3d |
| Tammy RomoDirector | Sold | 4,922 | $264.15 | $1.3M | Aug 6, 2026 | 4d |
| Roy BluntDirector | Sold | 600 | $262.68 | $158K | Aug 5, 2026 | 2d |
| Lisa Y. FooEVP, Chief Operating Officer | Sold | 10,000 | $258.03 | $2.6M | Jul 29, 2026 | 2d |
| Paola M. ArbourEVP, Chief Information Officer | Sold | 10,878 | $243.90 | $2.7M | Jul 27, 2026 | 1d |
| Christopher S. LynchDirector | Sold | 3,837 | $243.44 | $934K | Jul 27, 2026 | 1d |
| James L. BiermanDirector | Sold | 5,000 | $244.96 | $1.2M | Jul 27, 2026 | 1d |
| J. Robert KerreyDirector | Sold · 5 lines | 5,638 | $174.52 | $984K | May 28, 2026 | 1d |
| Nadja WestDirector | Sold | 3,000 | $177.35 | $532K | May 27, 2026 | 1d |
| Paola M. ArbourEVP, Chief Information Officer | Sold | 6,500 | $238.43 | $1.5M | Mar 11, 2026 | 2d |
| Thomas W. ArnstEVP, Chief Admin. Officer & GC | Sold · 2 lines | 8,000 | $238.85 | $1.9M | Mar 9, 2026 | 1d |
| R. Scott RamseyPrincipal Accounting Officer | Sold · 3 lines | 8,017 | $232.70 | $1.9M | Mar 2, 2026 | 1d |
| Thomas W. ArnstEVP, Chief Admin. Officer & GC | Sold | 24,000 | $234.04 | $5.6M | Mar 2, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in THC
9 disclosures of 9 on record · median 39d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Jonathan L. JacksonSpouse | Stock | Sale | $1,001 - $15,000 | +39.0%S&P +8.9% · vs S&P 500 +30.1% | Apr 15, 2026 | May 27, 2026 | 42d |
| Jonathan L. JacksonJoint | Stock | Sale | $15,001 - $50,000 | +40.7%S&P +7.6% · vs S&P 500 +33.1% | Apr 20, 2026 | May 27, 2026 | 37d |
| Jonathan L. JacksonSpouse | Stock | Sale | $1,001 - $15,000 | +18.9%S&P +10.1% · vs S&P 500 +8.7% | Feb 11, 2026 | Mar 12, 2026 | 29d |
| Jonathan L. JacksonJoint | Stock | Purchase | $15,001 - $50,000 | +36.3%S&P +10.9% · vs S&P 500 +25.4% | Dec 10, 2025 | Jan 8, 2026 | 29d |
| Jonathan L. JacksonSpouse | Stock | Purchase | $1,001 - $15,000 | +44.0%S&P +18.5% · vs S&P 500 +25.5% | Sep 3, 2025 | Oct 15, 2025 | 42d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +65.0%S&P +21.0% · vs S&P 500 +44.0% | Aug 4, 2025 | Sep 12, 2025 | 39d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +64.6%S&P +27.0% · vs S&P 500 +37.7% | Jun 11, 2025 | Aug 13, 2025 | 63d |
| John James | Stock | Sale | $1,001 - $15,000 | +66.0%S&P +38.4% · vs S&P 500 +27.6% | Sep 4, 2024 | Sep 6, 2024 | 2d |
| John JamesFiled late | Stock | Purchase | $1,001 - $15,000 | +400.2%S&P +73.1% · vs S&P 500 +327.1% | Nov 10, 2023 | Sep 2, 2024 | 297d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Cecil D. HaneyDirector | Gift | 150 | Aug 28, 2026 |
| Meghan FitzgeraldDirector | Stock award | 1,188 | May 27, 2026 |
| Vineeta AgarwalaDirector | Stock award | 1,188 | May 27, 2026 |
| Roy BluntDirector | Stock award | 1,188 | May 27, 2026 |
| Richard J. MarkDirector | Stock award | 1,188 | May 27, 2026 |
| Nadja WestDirector | Stock award | 1,188 | May 27, 2026 |
| Richard W. FisherDirector | Stock award | 1,188 | May 27, 2026 |
| Cecil D. HaneyDirector | Stock award | 1,188 | May 27, 2026 |
| James L. BiermanDirector | Stock award | 1,188 | May 27, 2026 |
| Tammy RomoDirector | Stock award | 1,188 | May 27, 2026 |
| Christopher S. LynchDirector | Stock award | 1,188 | May 27, 2026 |
| J. Robert KerreyDirector | Stock award | 1,464 | May 27, 2026 |
| Nadja WestDirector | Disposed to issuer | 493 | May 22, 2026 |
| Roy BluntDirector | Disposed to issuer | 493 | May 22, 2026 |
| Roy BluntDirector | Option exercise | 1,333 | May 22, 2026 |
| J. Robert KerreyDirector | Disposed to issuer | 607 | May 22, 2026 |
| J. Robert KerreyDirector | Option exercise | 1,643 | May 22, 2026 |
| Richard J. MarkDirector | Disposed to issuer | 493 | May 22, 2026 |
| Richard J. MarkDirector | Option exercise | 1,333 | May 22, 2026 |
| Cecil D. HaneyDirector | Disposed to issuer | 493 | May 22, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling THC?
Across the 18 most recent open-market filings shown here, 0 were purchases and 18 were sales.
Which members of Congress have traded THC?
Jonathan L. Jackson, Lisa C. McClain, John James disclosed THC transactions in the filings shown here.
How quickly are THC trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
